Results 11 to 20 of about 284,309 (242)

Long-term efficacy and safety of different corticosteroid courses plus mycophenolate mofetil for autoimmune encephalitis with neuronal surface antibodies without tumor

Frontiers in Immunology, 2023
ObjectiveTo compare the efficacy and safety of different-course corticosteroids plus mycophenolate mofetil (MMF) as maintenance therapy in autoimmune encephalitis (AE) with neuronal surface antibodies (NSAbs) without tumor and explore the optimal course ...
Dong Li, Teng Huang, Teng Huang, Fangyuan Zhang, Xiaoyu Zhang, Jingjing Dou, Chunjuan Wang, Shougang Guo, Shougang Guo   +8 more
doaj   +1 more source

Eosinophilic fasciitis: a case series with an emphasis on therapy and induction of remission

Drugs in Context, 2018
Eosinophilic fasciitis is an uncommon connective tissue disorder that affects patients of all ages, resulting in significant morbidity. Systemic corticosteroids can induce remission of disease.
Rechelle Tull, William D Hoover III, Jacqueline F De Luca, William W Huang , Joseph L Jorizzo   +4 more
doaj   +1 more source

Immune-Related Adverse Events and Corticosteroid Use for Cancer-Related Symptoms Are Associated With Efficacy in Patients With Non-small Cell Lung Cancer Receiving Anti-PD-(L)1 Blockade Agents

Frontiers in Oncology, 2020
Background: Immune-related adverse events (irAEs) have been associated with improved efficacy in advanced non-small cell lung cancer (NSCLC) patients receiving anti-PD-(L)1 blockade agents, while the concurrent use of corticosteroids seems to worsen it ...
Mariona Riudavets, Mariona Riudavets, Joaquin Mosquera, Rosario Garcia-Campelo, Jorgina Serra, Georgia Anguera, Pablo Gallardo, Ivana Sullivan, Andrés Barba, Luís del Carpio, Agustí Barnadas, Ignasi Gich, Ignasi Gich, Ignasi Gich, Margarita Majem   +14 more
doaj   +1 more source

Application of biomaterials in experimentally induced alveolar bone osteoporosis [PDF]

Stomatološki glasnik Srbije, 2003
Rehabilitation of alveolar bone with tissue defect caused by advanced osteoporosis is a common problem in stomatology and maxillofacial surgery. One of therapeutic approaches is implantation of biomaterials.
Ajduković Zorica R., Mihailović Dragan S., Najman Stevo J., Savić Vojin P., Aleksov Ljiljana, Stanković Saša, Krunić Nebojša, Ristić Kitka   +7 more
doaj   +1 more source

COVID-19 Acute Respiratory Distress Syndrome: Treatment with Helmet CPAP in Respiratory Intermediate Care Unit by Pulmonologists in the Three Italian Pandemic Waves

Advances in Respiratory Medicine, 2023
COVID-19 Acute Respiratory Distress Syndrome (CARDS) is the most serious complication of COVID-19. The SARS-CoV-2 outbreaks rapidly saturated intensive care unit (ICU), forcing the application of non-invasive respiratory support (NIRS) in respiratory ...
Martina Piluso, Clarissa Ferrari, Silvia Pagani, Pierfranco Usai, Stefania Raschi, Luca Parachini, Elisa Oggionni, Chiara Melacini, Francesca D’Arcangelo, Roberta Cattaneo, Cristiano Bonacina, Monica Bernareggi, Serena Bencini, Marta Nadalin, Mara Borelli, Roberto Bellini, Maria Chiara Salandini, Paolo Scarpazza   +17 more
doaj   +1 more source

Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A series of cases

Revista Alergia México, 2019
Background: Atopic dermatitis (AD) is a chronic skin disease that affects 5-20% of children. This disease compromises the quality of life. Omalizumab offers a promising role in the treatment of severe atopic dermatitis.
María García, Alejandro Durán-Crane, Edgardo Chapman, Elizabeth García   +3 more
doaj   +1 more source

Efficacy/Safety of the Use of Glucocorticoids in Oral and Maxillofacial Surgery

Dentistry Journal, 2023
Introduction: Glucocorticoids, also known as corticosteroids or steroids, are drugs derived from cholesterol. They are synthesized by the adrenal cortex, along with other hormones, such as cortisol and aldosterone.
Heilyn Joanna Nils, Cristina Arce Recatala, Antonio Castano, David Ribas, Javier Flores-Fraile   +4 more
doaj   +1 more source

Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema

Pharmaceutics, 2022
Diabetic retinopathy (DR) is one of the leading causes of blindness worldwide. Multiple treatment options have been used over time to attempt to modify the natural progression of the disease in both proliferative diabetic retinopathy (PDR) and diabetic ...
Jesus H. Gonzalez-Cortes, Victor A. Martinez-Pacheco, Jesus E. Gonzalez-Cantu, Alper Bilgic, Francesc March de Ribot, Aditya Sudhalkar, Jesus Mohamed-Hamsho, Laurent Kodjikian, Thibaud Mathis   +8 more
doaj   +1 more source

Inner Ear Pharmacotherapy for Residual Hearing Preservation in Cochlear Implant Surgery: A Systematic Review

Biomolecules, 2022
Cochlear implantation initiates an inflammatory cascade in which both acute insertion trauma and chronic foreign body reaction lead to intracochlear fibrosis and loss of residual hearing.
Quentin-Alexandre Parys, Pauline Van Bulck, Elke Loos, Nicolas Verhaert   +3 more
doaj   +1 more source

Corticosteroids for diabetic macular edema

Taiwan Journal of Ophthalmology, 2019
Diabetic macular edema (DME) is a chronic condition with a multifactorial pathogenesis. Vascular endothelial growth factor (VEGF) and several inflammatory mediators are upregulated in eyes with DME.
Jorge Chawan-Saad, Max Wu, Andres Wu, Lihteh Wu   +3 more
doaj   +1 more source